Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetings.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has submitted a disclosure to the NSE regarding its schedule of upcoming meetings with analysts and institutional investors. The filing itself is a routine corporate communication notifying the exchange about investor engagements. No specific dates, agenda items, or financial details have been disclosed in the headline. The full schedule details would typically be found in the attached document on the NSE portal.
This is a standard regulatory disclosure and is unlikely to move the stock price on its own. However, these meetings sometimes hint at upcoming strategic announcements, earnings previews, or business updates that investors should watch for.